Literature DB >> 18629629

Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women.

Lina Zhang1, Lin Gu, Biyun Qian, Xishan Hao, Wei Zhang, Qingyi Wei, Kexin Chen.   

Abstract

Estrogen plays a role in breast cancer development, and genetic polymorphisms in estrogen receptor gene ER-alpha and genes regulating estrogen biosynthesis and metabolisms are associated with the risk of breast cancer in women in western countries. Therefore, we hypothesized that SNPs in ER-alpha and other estrogen-metabolizing genes contribute to breast cancer risk in Chinese women. In this study, we genotyped polymorphisms in the regulatory regions of ER-alpha (rs3798577) and other two estrogen-metabolizing enzyme genes CYP17 (rs743572) and CYP19 (rs10046) among 300 breast cancer cases and 390 controls in a Chinese population. Crude and adjusted odds ratios (aORs) and 95% confidence intervals (CIs) were calculated by unconditional logistic regression analyses to estimate breast cancer risk associated with these polymorphisms. We found that the T allele frequency of ER-alpha was significantly higher in cases (59.8%) than controls (54.5%) (P = 0.047), but no significant difference was found in the genotype distribution. However, postmenopausal breast cancer risk was associated with the CYP17 TC genotype (aOR = 1.77, 95% CI = 1.11-2.83) compared with the TT genotype. The CYP19 variant TC + TT genotypes were associated with both overall cancer risk (TT + TC vs. TT aOR = 1.73, 95% CI = 1.13-2.65) and premenopausal cancer risk (TT + TC vs. TT aOR = 1.78, 95% CI = 1.03-3.09), particularly for ER +/PR + tumors. Furthermore, there were joint effects between CYP19 T and ER-alpha T variant genotypes (aOR = 1.67, 95% CI = 1.03-2.69 for CYP19 TC + TT vs. CC among ER-alpha T variant carriers) and between CYP19 T and CYP17 C variant genotypes (aOR = 1.77, 95% CI = 1.11-2.83 for CYP19 TC + TT vs. CC among CYP17 variant C carriers). This study provides evidence that polymorphisms CYP17 rs743572, CYP19 rs10046 and ER-alpha rs3798577 are associated with breast cancer risk among Chinese women.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18629629     DOI: 10.1007/s10549-008-9998-0

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  25 in total

1.  Functional variable number of tandem repeats variation in the promoter of proto-oncogene PTTG1IP is associated with risk of estrogen receptor-positive breast cancer.

Authors:  Chan Xiang; Haidong Gao; Lei Meng; Zhaoyu Qin; Rong Ma; Yang Liu; Yan Jiang; Chengxue Dang; Li Jin; Fuchu He; Haijian Wang
Journal:  Cancer Sci       Date:  2012-04-12       Impact factor: 6.716

2.  Polymorphic variants in TSC1 and TSC2 and their association with breast cancer phenotypes.

Authors:  Madhura S Mehta; Alexei Vazquez; Diptee A Kulkarni; John E Kerrigan; Gurinder Atwal; Shoichi Metsugi; Deborah L Toppmeyer; Arnold J Levine; Kim M Hirshfield
Journal:  Breast Cancer Res Treat       Date:  2010-07-25       Impact factor: 4.872

3.  Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium.

Authors:  Qiuyin Cai; Jirong Long; Wei Lu; Shimian Qu; Wanqing Wen; Daehee Kang; Ji-Young Lee; Kexin Chen; Hongbing Shen; Chen-Yang Shen; Hyuna Sung; Keitaro Matsuo; Christopher A Haiman; Ui Soon Khoo; Zefang Ren; Motoki Iwasaki; Kai Gu; Yong-Bing Xiang; Ji-Yeob Choi; Sue K Park; Lina Zhang; Zhibin Hu; Pei-Ei Wu; Dong-Young Noh; Kazuo Tajima; Brian E Henderson; Kelvin Y K Chan; Fengxi Su; Yoshio Kasuga; Wenjing Wang; Jia-Rong Cheng; Keun-Young Yoo; Jong-Young Lee; Hong Zheng; Yao Liu; Ya-Lan Shieh; Sung-Won Kim; Jong Won Lee; Hiroji Iwata; Loic Le Marchand; Sum Yin Chan; Xiaoming Xie; Shoichiro Tsugane; Min Hyuk Lee; Shenming Wang; Guoliang Li; Shawn Levy; Bo Huang; Jiajun Shi; Ryan Delahanty; Ying Zheng; Chun Li; Yu-Tang Gao; Xiao-Ou Shu; Wei Zheng
Journal:  Hum Mol Genet       Date:  2011-09-09       Impact factor: 6.150

4.  Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of chinese, Japanese, and European ancestry.

Authors:  Qiuyin Cai; Wanqing Wen; Shimian Qu; Guoliang Li; Kathleen M Egan; Kexin Chen; Sandra L Deming; Hongbing Shen; Chen-Yang Shen; Marilie D Gammon; William J Blot; Keitaro Matsuo; Christopher A Haiman; Ui Soon Khoo; Motoki Iwasaki; Regina M Santella; Lina Zhang; Alecia Malin Fair; Zhibin Hu; Pei-Ei Wu; Lisa B Signorello; Linda Titus-Ernstoff; Kazuo Tajima; Brian E Henderson; Kelvin Y K Chan; Yoshio Kasuga; Polly A Newcomb; Hong Zheng; Yong Cui; Furu Wang; Ya-Lan Shieh; Hiroji Iwata; Loic Le Marchand; Sum Yin Chan; Martha J Shrubsole; Amy Trentham-Dietz; Shoichiro Tsugane; Montserrat Garcia-Closas; Jirong Long; Chun Li; Jiajun Shi; Bo Huang; Yong-Bing Xiang; Yu-Tang Gao; Wei Lu; Xiao-Ou Shu; Wei Zheng
Journal:  Cancer Res       Date:  2011-02-08       Impact factor: 12.701

5.  Genetic polymorphism of ESR1 rs2881766 increases breast cancer risk in Korean women.

Authors:  Byung Ho Son; Mi Kyung Kim; Young Mi Yun; Hee Jeong Kim; Jong Han Yu; Beom Seok Ko; Hanna Kim; Sei Hyun Ahn
Journal:  J Cancer Res Clin Oncol       Date:  2014-10-17       Impact factor: 4.553

6.  Serum estradiol should be monitored not only during the peri-menopausal period but also the post-menopausal period at the time of aromatase inhibitor administration.

Authors:  Taeko Nagao; Misako Kira; Masako Takahashi; Junko Honda; Toshiyuki Hirose; Akira Tangoku; Hitoshi Zembutsu; Yusuke Nakamura; Mitsunori Sasa
Journal:  World J Surg Oncol       Date:  2009-11-12       Impact factor: 2.754

7.  Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls.

Authors:  Wei Zheng; Ben Zhang; Qiuyin Cai; Hyuna Sung; Kyriaki Michailidou; Jiajun Shi; Ji-Yeob Choi; Jirong Long; Joe Dennis; Manjeet K Humphreys; Qin Wang; Wei Lu; Yu-Tang Gao; Chun Li; Hui Cai; Sue K Park; Keun-Young Yoo; Dong-Young Noh; Wonshik Han; Alison M Dunning; Javier Benitez; Daniel Vincent; Francois Bacot; Daniel Tessier; Sung-Won Kim; Min Hyuk Lee; Jong Won Lee; Jong-Young Lee; Yong-Bing Xiang; Ying Zheng; Wenjin Wang; Bu-Tian Ji; Keitaro Matsuo; Hidemi Ito; Hiroji Iwata; Hideo Tanaka; Anna H Wu; Chiu-chen Tseng; David Van Den Berg; Daniel O Stram; Soo Hwang Teo; Cheng Har Yip; In Nee Kang; Tien Y Wong; Chen-Yang Shen; Jyh-Cherng Yu; Chiun-Sheng Huang; Ming-Feng Hou; Mikael Hartman; Hui Miao; Soo Chin Lee; Thomas Choudary Putti; Kenneth Muir; Artitaya Lophatananon; Sarah Stewart-Brown; Pornthep Siriwanarangsan; Suleeporn Sangrajrang; Hongbing Shen; Kexin Chen; Pei-Ei Wu; Zefang Ren; Christopher A Haiman; Aiko Sueta; Mi Kyung Kim; Ui Soon Khoo; Motoki Iwasaki; Paul D P Pharoah; Wanqing Wen; Per Hall; Xiao-Ou Shu; Douglas F Easton; Daehee Kang
Journal:  Hum Mol Genet       Date:  2013-03-27       Impact factor: 6.150

8.  Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium.

Authors:  Jirong Long; Qiuyin Cai; Xiao-Ou Shu; Shimian Qu; Chun Li; Ying Zheng; Kai Gu; Wenjing Wang; Yong-Bing Xiang; Jiarong Cheng; Kexin Chen; Lina Zhang; Hong Zheng; Chen-Yang Shen; Chiun-Sheng Huang; Ming-Feng Hou; Hongbing Shen; Zhibin Hu; Furu Wang; Sandra L Deming; Mark C Kelley; Martha J Shrubsole; Ui Soon Khoo; Kelvin Y K Chan; Sum Yin Chan; Christopher A Haiman; Brian E Henderson; Loic Le Marchand; Motoki Iwasaki; Yoshio Kasuga; Shoichiro Tsugane; Keitaro Matsuo; Kazuo Tajima; Hiroji Iwata; Bo Huang; Jiajun Shi; Guoliang Li; Wanqing Wen; Yu-Tang Gao; Wei Lu; Wei Zheng
Journal:  PLoS Genet       Date:  2010-06-24       Impact factor: 5.917

9.  Associations between CYP19A1 polymorphisms, Native American ancestry, and breast cancer risk and mortality: the Breast Cancer Health Disparities Study.

Authors:  Stephanie D Boone; Kathy B Baumgartner; Richard N Baumgartner; Avonne E Connor; Christina M Pinkston; Shesh N Rai; Elizabeth C Riley; Lisa M Hines; Anna R Giuliano; Esther M John; Mariana C Stern; Gabriela Torres-Mejía; Roger K Wolff; Martha L Slattery
Journal:  Cancer Causes Control       Date:  2014-08-05       Impact factor: 2.506

10.  Associations between aromatase CYP19 rs10046 polymorphism and breast cancer risk: from a case-control to a meta-analysis of 20,098 subjects.

Authors:  Begoña Pineda; Miguel Ángel García-Pérez; Antonio Cano; Ana Lluch; Pilar Eroles
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.